Morbidity of open retroperitoneal lymph node dissection for testicular cancer: Contemporary perioperative data

BJU International

Volumn 105, Issue 7, 2010, Pages 918-921

  Williams, Stephen B ^a   McDermott, David W ^a   Winston, Dock ^a   Bahnson, Eamonn ^a   Berry, Alexander M ^a   Steele, Graeme S ^a   Richie, Jerome P ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Morbidity; Retroperitoneal lymph node dissection; Testicular cancer

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE;

ADULT; AORTA INJURY; ARTICLE; CANCER INVASION; CHYLOUS ASCITES; CONTROLLED STUDY; EMBRYONAL CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ILEUS; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIPLE CYCLE TREATMENT; OPERATION DURATION; ORCHIECTOMY; PERIOPERATIVE COMPLICATION; POSTOPERATIVE PAIN; PRIORITY JOURNAL; TESTIS CANCER;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; EPIDEMIOLOGIC METHODS; HUMANS; LYMPH NODE EXCISION; MALE; NEOPLASMS, GERM CELL AND EMBRYONAL; RETROPERITONEAL SPACE; TESTICULAR NEOPLASMS; TREATMENT OUTCOME;

EID: 77749265092     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2009.08888.x     Document Type: Article

References (19)

1. Albers P, Siener R, Krege S et al. Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study Group. J Clin Oncol 2008 26 : 2966 2972
2. Steiner H, Peschel R, Janetschek G et al. Long term results of laparoscopic retroperitoneal lymph node dissection: a single center 10-year experience. Urology 2004 63 : 550 555
3. Beck S, Peterson MD, Bihrle R, Donohue JP, Foster RS. Short term morbidity of primary retroperitoneal lymph node dissection in a contemporary group of patients. J Urol 2007 178 : 504 506
4. Richie JP. Clinical stage 1 testicular cancer: the role of modified retroperitoneal lymphadenectomy. J Urol 1990 144 : 1160 1163
5. Donohue JP, Foster RS, Rowland RG, Bihrle R, Jones J, Geier G. Nerve-sparing retroperitoneal lymphadenectomy with preservation of ejaculation. J Urol 1990 144 : 287 291
6. Donohue JP, Foster RS. Retroperitoneal lymphadenectomy in staging and treatment. The development of nerve-sparing techniques. Urol Clin North Am 1998 25 : 461 468
7. Poulakis V, Skriapas K, de Vries R et al. Quality of life after laparoscopic and open retroperitoneal lymph node dissection in clinical Stage I nonseminomatous germ cell tumor: a comparison study. Urology 2006 68 : 154 160
8. Nielsen ME, Lima G, Schaeffer EM et al. Oncologic efficacy of laparoscopic RPLND in treatment of clinical stage I nonseminomatous germ cell testicular cancer. Urology 2007 70 : 1168 1172
9. Rassweiler JJ, Scheitlin W, Heidenreich A, Laguna MP, Janetschek G. Laparoscopic retroperitoneal lymph node dissection: does it still have a role in the management of clinical stage I nonseminomatous testis cancer? A European perspective. Eur Urol 2008 54 : 1004 1015
10. Nicolai N, Biasoni D, Aguilera JP et al. Contemporary series of open and laparoscopic retroperitoneal lymph node dissection (RPLND) in clinical stage I non-seminomatous germ cell tumors (NSGCTS): data from a single institution. J Urol 2009 181 : 323 324
11. Calestroupat JP, Sanchez-Salas R, Cathelineau X et al. Postchemotherapy laparoscopic retroperitoneal lymph node dissection in nonseminomatous germ-cell tumor. J Endourol 2009 23 : 645 650
12. Palese MA, Su LM, Kavoussi LR. Laparoscopic retroperitoneal lymph node dissection after chemotherapy. Urology 2002 60 : 130 134
13. Spermon JR, Witjes JA. Case report: The danger of postchemotherapy laparoscopic retroperitoneal lymph node dissection for nonseminomatous testicular carcinoma. J Endourol 2008 22 : 1013 1016
14. Bohlen D, Borner M, Sonntag RW, Fey MF, Studer UE. Long-term results following adjuvant chemotherapy in patients with clinical stage I nonseminomatous malignant germ cell tumors with high risk factors. J Urol 1999 161 : 1148 1152
15. Chevreau C, Mazerolles C, Soulie M et al. Long term efficacy of two cycles of BEP regimen in high-risk stage I nonseminomatous testicular germ cell tumors with embryonal carcinoma and/or vascular invasion. Eur Urol 2004 46 : 209 214
16. Stephenson AJ, Bosl GJ, Motzer RJ, Bajorin DF, Stasi JP, Sheinfeld J. Nonrandomized comparison of primary chemotherapy and retroperitoneal lymph node dissection for clinical stage IIA and IIB nonseminomatous germ cell testicular cancer. J Clin Oncol 2007 25 : 5597 5602
17. Brenner DJ, Hall EJ. Computed tomography-an increasing source of radiation exposure. N Engl J Med 2007 357 : 2277 2284
18. Brenner DJ, Elliston CD. Estimated radiation risks potentially associated with full-body CT screening. Radiology 2004 232 : 735 738
19. Tarin TV, Sonn G, Shinghal R. Estimating the risk of cancer associated with imaging related radiation during surveillance for stage I testicular cancer using computerized tomography. J Urol 2009 181 : 627 632